Arkolith/Insider Trading/INDV/Form 4

Heidbreder Christian

Chief Scientific OfficerIndivior Pharmaceuticals, Inc. (INDV) · full profile →Form 4 · filed Feb 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2026Grant(A)34K—$0191K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Grant(A)133K—$0133K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002014639-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML